HEMOSTASIS COAGULATION ROUTINE REAGENTS FACTOR ASSAYS CHROMOGENIC ASSAYS FACTOR VIII

TECHNOCHROM® FVIII:C

Colorimetric assay kit for Factor VIII in hemostasis.

The TECHNOCHROM® FVIII: C kit contains reagents for the colorimetric determination of the activity of FVIII in plasma and in plasma derivatives.

Advantages

- 24 hour stability of reagents on analyzers
- Reagents refreezable 14 days at -20 ° C
- Insensitivity of TECHNOCHROM FVIII: C reagent to Emicizumab

Informations

Factor VIII is a glycoprotein mainly synthesized by the liver. It circulates in the plasma as bound to vWF which protects it from rapid proteolytic degradation.
It is activated by FXa or thrombin in FVIIIa which will complex with FIXa in the presence of phospholipids to activate FX in FXa.
A patient who is deficient in FVIII has hemophilia A.

Documentation

Download the product sheet

Price list, safety data sheets and notices are accessible to our registered customers.

Colorimetric assay

References

4-5344101	Kit	2 x 50 tests

FVIII insufficiency as well as FVIII replacement therapy can be monitored. (Specialized hemostasis)

- Linearity: 1 - 144 (activity%).
- Detection limit: 0% (activity%)
- 5 minutes incubation and 3 minutes reading
- End point or kinetic

- 2 vials of FXa-1 + αNAPAP substrate (2 mL)
- 2 vials x reagent A (Phospholipid, Albumin) (2 mL)
- 2 vials x reagent B (FIXaß, FX, Ca ++ , Albumin, Thrombin) (2 mL)
- 1 bottle x ref. Stand. FVIII 1 (≈ 130%) (1 mL)
- 1 bottle x ref. Stand. FVIII 2 (≈ 70%) (1 mL)
- 1 bottle x ref. Stand. FVIII 3 (≈ 10%) (1 mL)
- 1 bottle x ref. Stand. FVIII 4 (<0.5%) (1 mL)
- 3 vials x FVIII dilution buffer (30 mL)
- 2 vials x FVIII reaction buffer (8 mL)

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE REAGENTS FACTOR ASSAYS CHROMOGENIC ASSAYS FACTOR VIII

TECHNOCHROM® FVIII:C

Colorimetric assay kit for Factor VIII in hemostasis.

Advantages

Informations

Documentation

Price list, safety data sheets and notices are accessible to our registered customers.

Colorimetric assay

References

Cryopep Catalogue
Thrombosis Haemostasis 2025

Cryopep Catalogue
Haemostasis Research 2025

Cryopep FACTOR ASSAYS

Product sheet TECHNOCHROM® FVIII:C

ISTH 2021 Measuring Chromogenic FVIII mimetic activity of the new bispecific antibody, Mim8, in atificialy spiked severe hemophilia A plasma

ISTH 2021 Measurement of FVIII in the presence of emicizumab is dependent on the chromogenic assay selected for use

ISTH 2019 Use of Chromogenic FVIII activity determination in Haemophilia A plasma of patients under Emicizumab Treatment

Related products: 3

Coagulation Control A

Coagulation Control N

Coagulation Reference

You must identify yourself to search for a certificate of analysis

HEMOSTASIS COAGULATION ROUTINE REAGENTS FACTOR ASSAYS CHROMOGENIC ASSAYS FACTOR VIII

TECHNOCHROM® FVIII:C

Colorimetric assay kit for Factor VIII in hemostasis.

Advantages

Informations

Documentation

Price list, safety data sheets and notices are accessible to our registered customers.

Colorimetric assay

References

Related products: 3